Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000846
Filing Date
2024-06-05
Accepted
2024-06-05 17:19:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2757
  Complete submission text file 0001972362-24-000846.txt   4314
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Reporting) CIK: 0001364719 (see all company filings)

Type: 144

Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38359 | Film No.: 241023034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)